SEC24C deficiency causes trafficking and glycosylation abnormalities in an epileptic encephalopathy with cataracts and dyserythropoeisis
Authors
- N. Bögershausen
- B. Cavdarli
- T. Nagai
- M.P. Milev
- A. Wolff
- M. Mehranfar
- J. Schmidt
- D. Choudhary
- Ó. Gutiérrez-Gutiérrez
- L. Cyganek
- D. Saint-Dic
- A. Zibat
- K. Köhrer
- T.E. Wollenweber
- D. Wieczorek
- J. Altmüller
- T. Borodina
- D. Kaçar
- G. Haliloğlu
- Y. Li
- C. Thiel
- M. Sacher
- E.W. Knapik
- G. Yigit
- B. Wollnik
Journal
- JCI Insight
Citation
- JCI Insight 10 (9): e173484
Abstract
As a major component of intracellular trafficking, the coat protein complex II (COPII) is indispensable for cellular function during embryonic development and throughout life. The 4 SEC24 proteins (A–D) are essential COPII components involved in cargo selection and packaging. A human disorder corresponding to alterations of SEC24 function is currently known only for SEC24D. Here, we reported that biallelic loss of SEC24C leads to a syndrome characterized by primary microcephaly, brain anomalies, epilepsy, hearing loss, liver dysfunction, anemia, and cataracts in an extended consanguineous family with 4 affected individuals. We showed that knockout of sec24C in zebrafish recapitulated important aspects of the human phenotype. SEC24C-deficient fibroblasts displayed alterations in the expression of several COPII components as well as impaired anterograde trafficking to the Golgi, indicating a severe impact on COPII function. Transcriptome analysis revealed that SEC24C deficiency also affected the proteasome and autophagy pathways. Moreover, a shift in the N-glycosylation pattern and deregulation of the N-glycosylation pathway suggested a possible secondary alteration of protein glycosylation, linking the described disorder with the congenital disorders of glycosylation.